#Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all approved antibody therapies, a new Lancet study led by an Indian-origin researcher has revealed. pic.twitter.com/Zwu5joG4sZ— IANS (@ians_india) November 24, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


